DBV Technologies Reports First Quarter 2025 Financial Results
Provided By GlobeNewswire
Last update: Apr 30, 2025
Châtillon, France, April 30, 2025
DBV Technologies Reports First Quarter 2025 Financial Results
DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, today reported financial results for the First Quarter of 2025. The quarterly and three months financial statements were approved by the Board of Directors on April 30, 2025.
Read more at globenewswire.com
